HemaCare Corporation is a blood products and services company. The Company provides healthy and disease state human-derived primary blood cells and tissues derived from normal and mobilized peripheral blood, bone marrow and cord blood for biomedical research, supports cell therapy clinical trials and commercialization with apheresis collections, and provides a range of consulting services in standard operating procedure (SOP) development, personnel training, and quality and regulatory compliance. Its products include CryoStor CS10, CryoStor CS5, Mobilized PB Leukopak, Monouclear Cells and CD133+ Stem/Progenitor Cells, among others. It supports industry and academic organizations with apheresis collection services for preclinical research, clinical trials from Phase I through Phase III, and clinical cell therapy applications. It specializes in customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols.